PT  - JOURNAL ARTICLE
AU  - Spigel, David R
AU  - Albany, Costantine
AU  - Chisamore, Michael
AU  - Moynihan, Kelly D
AU  - DelNagro, Christopher
AU  - Visich, Jennifer
AU  - Axt, Matt
AU  - Liu, Xiaohan
AU  - Sayles, Mark
AU  - Pirzkall, Andrea
AU  - Buchbinder, Elizabeth I
TI  - 753 An open-label, phase 1a/b study of AB248, a CD8+ selective IL-2 mutein fusion protein, alone or in combination with pembrolizumab in patients with advanced solid tumors
AID  - 10.1136/jitc-2023-SITC2023.0753
DP  - 2023 Nov 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - A849--A849
VI  - 11
IP  - Suppl 1
4099  - http://jitc.bmj.com/content/11/Suppl_1/A849.short
4100  - http://jitc.bmj.com/content/11/Suppl_1/A849.full
SO  - J Immunother Cancer2023 Nov 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.